Clinicopathologic Features of Agranulocytosis in the Setting of Levamisole-Tainted Cocaine

被引:68
作者
Czuchlewski, David R. [1 ]
Brackney, Monica [3 ]
Ewers, Christina [3 ]
Manna, Jonaki [4 ]
Fekrazad, M. Houman [2 ]
Martinez, Afton [3 ]
Nolte, Kurt B. [1 ]
Hjelle, Brian [1 ]
Rabinowitz, Ian [2 ]
Curtis, Brian R. [5 ]
McFarland, Janice G. [5 ]
Baumbach, Joan [3 ]
Foucar, Kathryn [1 ]
机构
[1] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Div Hematol Oncol, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[3] New Mexico Dept Hlth, Santa Fe, NM USA
[4] Vancouver Isl Hlth Author, Vancouver, BC, Canada
[5] Blood Ctr Wisconsin, Milwaukee, WI USA
关键词
Agranulocytosis; Levamisole; Cocaine; CANCER; NEUTROPENIA; ANTIBODIES; FARMS;
D O I
10.1309/AJCPOPQNBP5THKP1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Levamisole is a known contaminant of cocaine and, via this route, has been associated with otherwise unexplained agranulocytosis. Levamisole is currently present in the majority of cocaine samples seized by the US Drug Enforcement Agency. We identified 20 cases of unexplained agranulocytosis in our practice locations of Albuquerque, NM, and Vancouver, Canada. Epidemiologic investigation revealed recent or ongoing cocaine use in 14 cases (70%). Certain morphologic features, including circulating plasmacytoid lymphocytes, increased bone marrow plasma cells, and mild megakaryocytic hyperplasia, were associated with the cocaine-exposed group. Of 5 patients tested, 3 (60%) were HLA-B27+ and showed antineutrophil antibodies, consistent with known associations of levamisole-induced agranulocytosis. One patient, Who was positive for Cocaine and levamisole by toxicology; testing, died of infectious complications. Inadvertent consumption of levamisole via cocaine is a severely underappreciated risk factor for agranulocytosis, and specific laboratory features are suggestive of this etiology.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 25 条
[1]   THE DOSAGE REGIMEN OF LEVAMISOLE IN CANCER - IS IT RELATED TO EFFICACY AND SAFETY [J].
AMERY, WK ;
BUTTERWORTH, BS .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (01) :1-9
[2]   LEVAMISOLE, THE STORY AND THE LESSONS [J].
AMERY, WKP ;
BRUYNSEELS, JPJM .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (03) :481-486
[3]  
Ann Marie M., 2005, MICROGRAM J, V3, P134
[4]  
CASALE JF, 2008, MICROGRAM J, V6
[5]   Human leukocyte antigens and drug hypersensitivity [J].
Chung, Wen-Hung ;
Hung, Shuen-Lu ;
Chen, Yuan-Tsong .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 7 (04) :317-323
[6]   National Cancer Institute Clinical Trials Program in colorectal cancer [J].
Conley, BA ;
Kaplan, RS ;
Arbuck, SG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) :S75-S79
[7]   Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH): a report of five cases [J].
Curtis, BR ;
Reno, C ;
Aster, RH .
TRANSFUSION, 2005, 45 (08) :1308-1313
[8]   Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group [J].
Dahl, Olav ;
Fluge, Oystein ;
Carlsen, Erik ;
Wiig, Johan N. ;
Myrvold, Helge E. ;
Vonen, Barthold ;
Podhorny, Nina ;
Bjerkeset, Ottar ;
Eide, Tor Jack ;
Halvorsen, Tore B. ;
Tveit, Kjell Magne .
ACTA ONCOLOGICA, 2009, 48 (03) :368-376
[9]   Neonatal neutropenia and bacterial sepsis associated with placental transfer of maternal neutrophil-specific autoantibodies [J].
Davoren, A ;
Saving, K ;
McFarland, JG ;
Aster, RH ;
Curtis, BR .
TRANSFUSION, 2004, 44 (07) :1041-1046
[10]  
DREW SI, 1979, TRANSPLANTATION, V27, P436